Cargando…

The Importance of Metabolic Syndrome Status for the Risk of Non-Viral Hepatocellular Carcinoma: A Nationwide Population-Based Study

The positive association between metabolic syndrome (MetS) and hepatocellular carcinoma (HCC) has been suggested. However, no studies have yet looked at how the risk of developing HCC varies with changes in MetS status. Therefore, we aimed to investigate the association between changes in MetS and s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Yuri, Cho, Eun Ju, Yoo, Jeong-Ju, Chang, Young, Chung, Goh Eun, Choi, In Young, Park, Sang-Hyun, Han, Kyungdo, Kim, Yoon Jun, Yoon, Jung-Hwan, Shin, Dong Wook, Yu, Su Jong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116136/ https://www.ncbi.nlm.nih.gov/pubmed/35600376 http://dx.doi.org/10.3389/fonc.2022.863352

Ejemplares similares

The association between alcohol consumption and the risk of hepatocellular carcinoma according to glycemic status in Korea: A nationwide population-based study
por: Cho, Eun Ju, et al.
Publicado: (2023)

Association between Lipid Profiles and the Incidence of Hepatocellular Carcinoma: A Nationwide Population-Based Study
por: Cho, Yuri, et al.
Publicado: (2021)

The Change in Metabolic Syndrome Status and the Risk of Nonviral Liver Cirrhosis
por: Chung, Goh-Eun, et al.
Publicado: (2021)

Gamma-glutamyl transferase and risk of all-cause and disease-specific mortality: a nationwide cohort study
por: Cho, Eun Ju, et al.
Publicado: (2023)

Association between the fatty liver index and the risk of fracture among individuals over the age of 50 years: a nationwide population-based study
por: Chung, Goh Eun, et al.
Publicado: (2023)

The association of fatty liver index and BARD score with all-cause and cause-specific mortality in patients with type 2 diabetes mellitus: a nationwide population-based study
por: Chung, Goh Eun, et al.
Publicado: (2022)

Differential risk of 23 site‐specific incident cancers and cancer‐related mortality among patients with metabolic dysfunction‐associated fatty liver disease: a population‐based cohort study with 9.7 million Korean subjects
por: Chung, Goh Eun, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease is associated with the development of obstructive sleep apnea
por: Chung, Goh Eun, et al.
Publicado: (2021)

Lean or diabetic subtypes predict increased all-cause and disease-specific mortality in metabolic-associated fatty liver disease
por: Chung, Goh Eun, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease Is a Precursor of New-Onset Metabolic Syndrome in Metabolically Healthy Young Adults
por: Yoo, Jeong-Ju, et al.
Publicado: (2022)

Smoking Increases the Risk of Hepatocellular Carcinoma and Cardiovascular Disease in Patients with Metabolic-Associated Fatty Liver Disease
por: Yoo, Jeong-Ju, et al.
Publicado: (2023)

Associations of Variability in Metabolic Parameters with Lung Cancer: A Nationwide Population-Based Study
por: Cho, In Young, et al.
Publicado: (2021)

Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib
por: Yoo, Jeong-Ju, et al.
Publicado: (2018)

Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients
por: Nam, Joon Yeul, et al.
Publicado: (2017)

Appraisal of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage B
por: Yoo, Jeong-Ju, et al.
Publicado: (2020)

Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma
por: Yoo, Jeong-Ju, et al.
Publicado: (2019)

Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14
por: Cho, Yuri, et al.
Publicado: (2016)

Factors associated with the survival outcomes of patients with untreated hepatocellular carcinoma: An analysis of nationwide data
por: Kwon, Min Jung, et al.
Publicado: (2023)

Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients
por: Chung, Goh Eun, et al.
Publicado: (2017)

Fucoidan protects hepatocytes from apoptosis and inhibits invasion of hepatocellular carcinoma by up-regulating p42/44 MAPK-dependent NDRG-1/CAP43
por: Cho, Yuri, et al.
Publicado: (2015)

Synergistic effect of ursodeoxycholic acid on the antitumor activity of sorafenib in hepatocellular carcinoma cells via modulation of STAT3 and ERK
por: Lee, Seulki, et al.
Publicado: (2018)

Percutaneous ethanol injection therapy is comparable to radiofrequency ablation in hepatocellular carcinoma smaller than 1.5 cm: A matched case–control comparative analysis
por: Yu, Su Jong, et al.
Publicado: (2016)

Real-world experiences of CNS-directed chemotherapy followed by autologous stem cell transplantation for secondary CNS involvement in relapsed or refractory diffuse large B-cell lymphoma
por: Jeong, Sun Young, et al.
Publicado: (2023)

Serum Insulin-Like Growth Factor-1 Predicts Disease Progression and Survival in Patients with Hepatocellular Carcinoma Who Undergo Transarterial Chemoembolization
por: Cho, EunJu, et al.
Publicado: (2014)

Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort study
por: Kim, Hwi Young, et al.
Publicado: (2018)

Current status and strategies for viral hepatitis control in Korea
por: Sinn, Dong Hyun, et al.
Publicado: (2017)

Impact of previous percutaneous coronary intervention on cardiovascular outcomes and mortality after lung cancer surgery: A nationwide study in Korea
por: Yoon, Dong Woog, et al.
Publicado: (2020)

CKD-5, a novel pan-histone deacetylase inhibitor, synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma
por: Chang, Young, et al.
Publicado: (2020)

Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area
por: Lee, Dong Hyeon, et al.
Publicado: (2017)

Association of Metabolic Parameter Variability with Esophageal Cancer Risk: A Nationwide Population-Based Study
por: Lee, Ji Eun, et al.
Publicado: (2022)

Adding MRI as a Surveillance Test for Hepatocellular Carcinoma in Patients with Liver Cirrhosis Can Improve Prognosis
por: Yu, Su Jong, et al.
Publicado: (2023)

3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells
por: Lee, Minjong, et al.
Publicado: (2017)

Female reproductive factors and the risk of lung cancer in postmenopausal women: a nationwide cohort study
por: Jeon, Keun Hye, et al.
Publicado: (2020)

Prognostic Values of Inflammation-Based Scores and Fibrosis Markers in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Cho, Eun Ju, et al.
Publicado: (2022)

Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea
por: Cho, Yuri, et al.
Publicado: (2015)

Survival Analysis of Single Large (>5 cm) Hepatocellular Carcinoma Patients: BCLC A versus B
por: Cho, Yuri, et al.
Publicado: (2016)

Changes in Metabolic Syndrome Status and Risk of Dementia
por: Lee, Ji Eun, et al.
Publicado: (2020)

Validation of P2/MS for reflecting hepatic fibrosis in patients with hepatocellular carcinoma
por: Yu, Su Jong, et al.
Publicado: (2010)

Combined Effects of Chronic Kidney Disease and Nonalcoholic Fatty Liver Disease on the Risk of Cardiovascular Disease in Patients with Diabetes
por: Chung, Goh-Eun, et al.
Publicado: (2022)

Timing of upper gastrointestinal endoscopy does not influence short-term outcomes in patients with acute variceal bleeding
por: Yoo, Jeong-Ju, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_el3lfrk2e1nj2je1m7fqsnru7j